Go Deep
Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 24,179 | -0.6 | 1.58 | 0.06 | 457.47 |
| Oct 2026 | 24,276 | -0.6 | 1.51 | 0.06 | 437.58 |
| Oct 2026 | 22,138 | -0.6 | 1.61 | 0.06 | 466.50 |
| Oct 2026 | 22,209 | -0.6 | 1.56 | 0.06 | 451.80 |
| Oct 2026 | 22,096 | -0.6 | 1.64 | 0.06 | 473.86 |
| Oct 2026 | 22,009 | -0.7 | 1.70 | 0.06 | 490.83 |
Curanex Pharmaceuticals Inc Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -3,290,970.0 | -3,150,228.0 | -3,073,118.0 | -954,059.0 |
| EPS | -2.4 | -2.2 | — | -0.8 |
Curanex Pharmaceuticals Inc Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 26,000.0 |
| Net Profit | -4,225,106.0 | -361,506.0 | -19,198.0 | -20,233.0 |
| EPS | -3.4 | -0.3 | -0.0 | -0.4 |
Curanex Pharmaceuticals Inc Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total Assets | 11,580,124.0 | 517,935.0 | 74,366.0 | 10,232.0 |
| Total Liabilities | 361,040.0 | 14,575.0 | 14,276.0 | 0.0 |
| Total Equity | 11,219,084.0 | 503,360.0 | 60,090.0 | 10,232.0 |
Owes vs Owns
Curanex Pharmaceuticals Inc owed $0.06 for every $1 it owned in Jun 2026, up from $0.00 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.06× | 0.03× | 0.03× | 0.19× | 0.00× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Curanex Pharmaceuticals Inc Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 42.9%Fixed assets (tangible) 3.0%Other assets 54.0%
How it's funded — Dec 2025
Short-term debt 1.1%Long-term debt 1.9%Shareholders' equity 96.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 5.0 | 0.1 | 0.1 | 0.0 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.4 | 0.0 | 0.0 | 0.0 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 6.3 | 0.4 | 0.0 | 0.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.2 | 0.0 | 0.0 | 0.0 |
| Payables | 0.0 | 0.0 | 0.0 | 0.0 |
| Other liabilities | 0.0 | 0.0 | 0.0 | 0.0 |
| Shareholders' equity | 11.2 | 0.5 | 0.1 | 0.0 |
| Net tangible assets | 11.2 | 0.5 | 0.1 | 0.0 |
Curanex Pharmaceuticals Inc Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Operating Activities | -10,484,452.0 | -555,575.0 | -120.0 | 3,336.0 |
| Financing Activities | 15,308,695.0 | 630,100.0 | 72,056.0 | -3,000.0 |